The pharmaceutical industry isn’t the first place investors turn to when looking for high-growth stocks. However, some companies in the field look so promising that they could deliver well-above-average returns through the end of the decade. There are several candidates here, but two of the most attractive today are Eli Lilly (NYSE: LLY) and Novo […]
Tag: Pharmaceutical
Second Henrietta Lacks family lawsuit can proceed against pharmaceutical company, judge rules
BALTIMORE — The family of Henrietta Lacks can proceed with a lawsuit against a pharmaceutical company that uses the Baltimore County woman’s “immortal” cell line to develop medical treatments, a federal judge ruled Monday. U.S. District Judge Deborah L. Boardman rejected a motion to dismiss the complaint against Ultragenyx Pharmaceutical, the second company to face […]
Alpha GPC Choline 75 Veggie Caps 700 mg per Serving Pharmaceutical Grade Non-GMO
1 Unstoppable Pharmaceutical Stock Investors Shouldn’t Sleep On
One of the hottest areas in the pharmaceutical space right now is weight loss. Glucagon-like peptide-1 (GLP-1) medications such as Ozempic, Wegovy, Rybelsus, Mounjaro, and Zepbound have become staples for treating diabetes and obesity. Eli Lilly (NYSE: LLY) is the developer of Mounjaro and Zepbound, two popular medications used to treat those conditions. The main […]
German pharmaceutical firm Merck lays cornerstone for research centre
The time capsule for the laying of the foundation stone is ready. The pharmaceutical and chemical company Merck is investing more than 300 million euros in a new research center at its headquarters in Darmstadt. Andreas Arnold/dpa German pharmaceutical and chemical company Merck is investing more than €300 million ($320 million) in a new research […]
French vintage Saint-Remy cloth bandages not to be used from 1950 pharmaceutical
Pharmaceutical giant Bayer is getting rid of bosses and asking nearly 100,000 workers to ‘self organize’ to save $2.15 billion
In a bid to claw back $2.15 billion, the struggling pharmaceutical giant Bayer CEO is doing away with middle managers and 99% of the company’s 1,362-page corporate handbook, allowing nearly 100,000 employees to self-manage. Bayer, the 160-year-old German company known for inventing aspirin, has been stuck in a rut; Its market cap has plunged to […]
3 Pharmaceutical Stocks to Buy Hand Over Fist in March
Pharmaceutical companies play a tremendous role in modern healthcare. While sometimes controversial, drugmakers design medicine to treat some of the worst ailments plaguing society and constantly innovate to improve human life. Their long-term relevance in healthcare makes the pharmaceutical business an excellent place for investors to find long-term investment ideas. These three stocks offer investors […]
Endo OPANAER Understanding Chronic Lower Back Pain Pharmaceutical Model 0P-0427
Here’s 1 Pharmaceutical Stock That Looks Unstoppable. Hint: It’s Not Novo Nordisk.
Diabetes and obesity medications are becoming wildly popular. Commercials for them dominate the airwaves on a daily basis — many produced by Novo Nordisk. This Danish pharmaceutical giant is the developer of glucagon-like peptide-1 (GLP-1) agonists Ozempic, Rybelsus, Wegovy. The success of these drugs has helped Novo Nordisk acquire a nearly 55% share of the […]
UPDATE 2-Teva to divest active pharmaceutical ingredient business
(Adds share movement in paragraph 3, background throughout) Jan 31 (Reuters) – Teva Pharmaceutical Industries will divest its active pharmaceutical ingredient (API) unit to focus on its core business, the world’s largest generic drugs maker said on Wednesday. The API unit, which brought in revenue of $1.05 billion in 2022, makes pharmaceutical ingredients that are […]
After Surging 53% in 2023, This Pharmaceutical Stock Might Be About to Crash. Here’s Why I’m Probably Wrong
Artificial intelligence (AI) wasn’t the only big investment theme last year. The pharmaceutical industry saw increased interest due to the popularity of new weight-monitoring treatments. In particular, Danish drug manufacturer Novo Nordisk (NYSE: NVO) enjoyed tailwinds fueled by demand over its flagship products Ozempic, Wegovy, Rybelsus, and Saxenda. The stock’s 53% return handily topped the […]